Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith Lindor

Showing results (31-40 of 65) with videos related to

Pageof 7
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 31, 2004
Do antinuclear antibodies in primary biliary cirrhosis patients identify increased risk for liver failure?Wei-Hong Yang, Jiang Hong Yu, Ayako Nakajima, et al.
Hepatology (Baltimore, Md.)|June 1, 2010
Drug-induced autoimmune hepatitis: clinical characteristics and prognosisEinar Björnsson, Jayant Talwalkar, Sombat Treeprasertsuk, et al.
Journal of Hepatology|September 6, 2005
Effect of changes on body weight and lifestyle in nonalcoholic fatty liver diseaseAyako Suzuki, Keith Lindor, Jenny St Saver, et al.
Journal of Hepatology|September 20, 2014
Unmet clinical need in autoimmune liver diseasesJessica K Dyson, Gwilym Webb, Gideon M Hirschfield, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 20, 2009
Fatigue measurements in patients with primary biliary cirrhosis and the risk of mortality during follow-upEinar Björnsson, Evangelos Kalaitzakis, Matthias Neuhauser, et al.
Journal of Gastroenterology and Hepatology|April 23, 2002
Tumor necrosis factor-alpha and transforming growth factor-beta reflect severity of liver damage in primary biliary cirrhosisManuela Neuman, Paul Angulo, Izabella Malkiewicz, et al.
Hepatology (Baltimore, Md.)|January 29, 2008
Low circulating levels of dehydroepiandrosterone in histologically advanced nonalcoholic fatty liver diseaseMichael Charlton, Paul Angulo, Naga Chalasani, et al.
Hepatology (Baltimore, Md.)|June 16, 2011
The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injuryAyako Suzuki, Elizabeth M Brunt, David E Kleiner, et al.
Hepatology (Baltimore, Md.)|October 19, 2011
Biochemical and immunologic effects of rituximab in patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acidMasanobu Tsuda, Yuki Moritoki, Zhe-Xiong Lian, et al.
Hepatology (Baltimore, Md.)|October 31, 2009
B-cell depletion with anti-CD20 ameliorates autoimmune cholangitis but exacerbates colitis in transforming growth factor-beta receptor II dominant negative miceYuki Moritoki, Zhe-Xiong Lian, Keith Lindor, et al.
Pageof 7

Showing results (31-40 of 65) with videos related to

Sort By:
Pageof 7
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 31, 2004
Do antinuclear antibodies in primary biliary cirrhosis patients identify increased risk for liver failure?Wei-Hong Yang, Jiang Hong Yu, Ayako Nakajima, et al.
Hepatology (Baltimore, Md.)|June 1, 2010
Drug-induced autoimmune hepatitis: clinical characteristics and prognosisEinar Björnsson, Jayant Talwalkar, Sombat Treeprasertsuk, et al.
Journal of Hepatology|September 6, 2005
Effect of changes on body weight and lifestyle in nonalcoholic fatty liver diseaseAyako Suzuki, Keith Lindor, Jenny St Saver, et al.
Journal of Hepatology|September 20, 2014
Unmet clinical need in autoimmune liver diseasesJessica K Dyson, Gwilym Webb, Gideon M Hirschfield, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 20, 2009
Fatigue measurements in patients with primary biliary cirrhosis and the risk of mortality during follow-upEinar Björnsson, Evangelos Kalaitzakis, Matthias Neuhauser, et al.
Journal of Gastroenterology and Hepatology|April 23, 2002
Tumor necrosis factor-alpha and transforming growth factor-beta reflect severity of liver damage in primary biliary cirrhosisManuela Neuman, Paul Angulo, Izabella Malkiewicz, et al.
Hepatology (Baltimore, Md.)|January 29, 2008
Low circulating levels of dehydroepiandrosterone in histologically advanced nonalcoholic fatty liver diseaseMichael Charlton, Paul Angulo, Naga Chalasani, et al.
Hepatology (Baltimore, Md.)|June 16, 2011
The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injuryAyako Suzuki, Elizabeth M Brunt, David E Kleiner, et al.
Hepatology (Baltimore, Md.)|October 19, 2011
Biochemical and immunologic effects of rituximab in patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acidMasanobu Tsuda, Yuki Moritoki, Zhe-Xiong Lian, et al.
Hepatology (Baltimore, Md.)|October 31, 2009
B-cell depletion with anti-CD20 ameliorates autoimmune cholangitis but exacerbates colitis in transforming growth factor-beta receptor II dominant negative miceYuki Moritoki, Zhe-Xiong Lian, Keith Lindor, et al.
Pageof 7